Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.

about

Correlation between Activated Partial Thromboplastin Time and Anti-Xa Activity in Patients Who Received Low-Molecular Weight Heparin as Anticoagulation for Haemodialysis.

P2860

Q38647013-28DDE2D1-E935-49DF-BA84-8A189E522FED

P2860

Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.

Item

http://www.wikidata.org/entity/Q51661966

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@en

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@nl

type

Item

label

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@en

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@nl

prefLabel

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@en

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@nl

P1476

Antifactor Xa levels vs. activ ...... onated heparin. A pilot study.

@en

P2093

A Nguyen

http://www.w3.org/2001/XMLSchema#string

G Ranjbar

http://www.w3.org/2001/XMLSchema#string

G Yau

http://www.w3.org/2001/XMLSchema#string

H A Choi

http://www.w3.org/2001/XMLSchema#string

M Escobar

http://www.w3.org/2001/XMLSchema#string

N Mckaig

http://www.w3.org/2001/XMLSchema#string

S Samuel

http://www.w3.org/2001/XMLSchema#string

S Sharaf

http://www.w3.org/2001/XMLSchema#string

T A Allison

http://www.w3.org/2001/XMLSchema#string

P2860

Challenges in variation and responsiveness of unfractionated heparin.

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.

To bleed or not to bleed? Is that the question for the PTT?

Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight.

High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients.

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration.

P304

499-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCPT.12415

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27381025

http://www.w3.org/2001/XMLSchema#string

Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.

about

P2860

P2860

Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698